Brown & Brown, Inc. (NYSE:BRO) is among the 11 Most Oversold S&P 500 Stocks Heading into 2026. On December 4, Citi analyst Matthew Heimermann maintained the firm’s Buy rating on the stock with a target price of $104, a reaffirmation of an earlier update on October 30.
The adjustment follows Morgan Stanley and Barclays’ updates to their stock price targets on BRO on November 17 and 20, when both firms reduced their price targets to $85 from $95 and $84 from $102, respectively. According to TheFly, the reductions were driven by weak pricing trends and a slowdown in the property and casualty markets.
Earlier, on November 3, BofA downgraded Brown & Brown, Inc. (NYSE:BRO) to Neutral from Buy and reduced its price target to $97 from $135, citing softening rates and macroeconomic uncertainties.
The reductions in price targets have come despite Brown & Brown, Inc. (NYSE:BRO) reporting a 35.4% year-over-year increase in net revenue for Q3 2025 that totaled $1.6 billion, driven by a 34.2% increase in commissions and fees. The company’s net income per share came in at $1.05, up 15% from the prior year’s period.
As of the close of business on December 10, Wall Street analysts hold a consensus Hold rating on the stock, with a one-year average share price target of $93.50, implying 21% upside.
Brown & Brown, Inc. (NYSE:BRO) is a global insurance intermediary that offers a broad range of insurance products and services. The stock is down 24% year-to-date.
While we acknowledge the potential of BRO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Top 15 Lowest P/E Ratios of the S&P 500 in 2025 and 10 Best Drone Stocks to Buy Right Now.
Disclosure: None.